HCB301M7824atezolizumabrituximabnon-Hodgkin’s lymphomaFDA
…F-β individually, in both FaDu and 4T1 tumor models.Conclusions HCB301 represents a novel therapeutic approach that simultaneously tar…
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: HCB301 ×
HCB301
This drug is selected. Its supporting articles are shown below.